Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Nonalcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02235233
What this trial is testing

Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin

Who this might be right for
Non-alcoholic Steatohepatitis
University of North Carolina, Chapel Hill 21
Not applicableLooking for participantsNCT05330923
What this trial is testing

Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisFibrosis+1 more
Peking Union Medical College Hospital 2,000
Not applicableStudy completedNCT03839082
What this trial is testing

Structured Mobile Technology Based Lifestyle Program vs Usual Care for Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-alcoholic Steatohepatitis
University of Michigan 75
Testing effectiveness (Phase 2)Study completedNCT05343780
What this trial is testing

Clinical Trial to Investigate the Anti-oxidant Activity of Heptex in Patients With Apparent Risk Factors of NASH

Who this might be right for
Nonalcoholic Steatohepatitis
Natural Wellness Egypt 142
Early research (Phase 1)Ended earlyNCT05864391
What this trial is testing

Investigate Safety, Tolerability, and Pharmacokinetics of AZD7503 in Participants With Suspected NASH.

Who this might be right for
Steatohepatitis
AstraZeneca 40
Not applicableLooking for participantsNCT05625750
What this trial is testing

Observational Study About Patients Diagnosed With NAFLD

Who this might be right for
Nonalcoholic Fatty Liver Disease
Xiangya Hospital of Central South University 500
Large-scale testing (Phase 3)Study completedNCT01791959
What this trial is testing

The Effects of Synbiotics Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Steatohepatitis
National Nutrition and Food Technology Institute 54
Not applicableUnknownNCT03487068
What this trial is testing

Assessment of Renal Changes in Patients With Non Alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseChronic Kidney Diseases
Assiut University 50
Testing effectiveness (Phase 2)UnknownNCT05083390
What this trial is testing

Norursodeoxycholic Acid vs. Placebo in NASH

Who this might be right for
Nonalcoholic Steatohepatitis
Dr. Falk Pharma GmbH 363
Not applicableNot Yet RecruitingNCT07713992
What this trial is testing

Efficacy and Safety of Mazdutide in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Nonalcoholic Fatty Liver Disease Previously Treated With Semaglutide

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Nonalcoholic Fatty Liver Disease (NAFLD) With History of Diabetes Melitus
Tianjin Medical University 72
Not applicableUnknownNCT06589167
What this trial is testing

Metabolic Syndrome and Fatty Liver Disease Among Egyptian Patients with Chronic HBV

Who this might be right for
Metabolic SyndromeFatty Liver Disease
Assiut University 100
Not applicableStudy completedNCT05866744
What this trial is testing

Effects of Time-restricted Hypocaloric Diet in Patients with NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Agricultural University of Athens 59
Testing effectiveness (Phase 2)Study completedNCT00666016
What this trial is testing

Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
Non-Alcoholic Steatohepatitis (NASH)
Hoffmann-La Roche 22
Not applicableStudy completedNCT01875978
What this trial is testing

Effect of Phytosterols on Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
China Medical University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT04235205
What this trial is testing

Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic Steatohepatitis
Yokohama City University 102
Not applicableStudy completedNCT01464801
What this trial is testing

Resveratrol in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Fatty Liver
University of Aarhus 28
Testing effectiveness (Phase 2)Study completedNCT03459079
What this trial is testing

Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)Type 2 Diabetes (T2DM)
University of Florida 128
Not applicableActive Not RecruitingNCT07007741
What this trial is testing

Digital Therapy for Fatty Liver Disease

Who this might be right for
Steatohepatitis, NonalcoholicNonalcoholic Fatty Liver
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 141
Not applicableLooking for participantsNCT07632677
What this trial is testing

Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)MASH - Metabolic Dysfunction-Associated SteatohepatitisMetabolic Dysfunction-associated Fatty Liver Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 10,000
Not applicableStudy completedNCT05320146
What this trial is testing

A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Corcept Therapeutics 22
Next Page